Regulating the regulator: Factors that control levels and activity of the aryl hydrocarbon receptor

Biochemical Pharmacology

Volumn 72, Issue 3, 2006, Pages 267-279

  Harper, Patricia A ^a,b   Riddick, David S ^b   Okey, Allan B ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin; AH receptor; Aryl hydrocarbon receptor; Dioxin; Expression; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALPHA NAPHTHOFLAVONE; ANTINEOPLASTIC AGENT; AROMATIC HYDROCARBON RECEPTOR; BETA NAPHTHOFLAVONE; DEXAMETHASONE; DIMETHYL SULFOXIDE; ESTRADIOL; GLUCOCORTICOID; PHENOBARBITAL; XENOBIOTIC AGENT;

ARTICLE; DEVELOPMENT; ENDOCRINE FUNCTION; GENETIC REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 33745656989     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.01.007     Document Type: Note

References (99)

1. Poland A., Glover E., and Kende A.S. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J Biol Chem 251 (1976) 4936-4946
2. Okey A.B., Bondy G.P., Mason M.E., Kahl G.F., Eisen H.J., Guenthner T.M., et al. Regulatory gene product of the Ah locus. Characterization of the cytosolic inducer-receptor complex and evidence for its nuclear translocation. J Biol Chem 254 (1979) 11636-11648
3. Poland A., and Knutson J.C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22 (1982) 517-554
4. Gu Y.Z., Hogenesch J.B., and Bradfield C.A. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40 (2000) 519-561
5. Elizondo G., Fernandez-Salguero P., Sheikh M.S., Kim G.Y., Fornace A.J., Lee K.S., et al. Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast. Mol Pharmacol 57 (2000) 1056-1063
6. Puga A., Xia Y., and Elferink C. Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem Biol Interact 141 (2002) 117-130
7. Puga A., Tomlinson C.R., and Xia Y. Ah receptor signals cross-talk with multiple developmental pathways. Biochem Pharmacol 69 (2005) 199-207
8. Walisser J.A., Bunger M.K., Glover E., and Bradfield C.A. Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development. Proc Natl Acad Sci USA 101 (2004) 16677-16682
9. Baba T., Mimura J., Nakamura N., Harada N., Yamamoto M., Morohashi K., et al. Intrinsic function of the aryl hydrocarbon (dioxin) receptor as a key factor in female reproduction. Mol Cell Biol 25 (2005) 10040-10051
10. Sloop T.C., and Lucier G.W. Dose-dependent elevation of Ah receptor binding by TCDD in rat liver. Toxicol Appl Pharmacol 88 (1987) 329-337
11. Franc M.A., Pohjanvirta R., Tuomisto J., and Okey A.B. Persistent, low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effect on aryl hydrocarbon receptor expression in a dioxin-resistance model. Toxicol Appl Pharmacol 175 (2001) 43-53
12. Kann S., Huang M.Y., Estes C., Reichard J.F., Sartor M.A., Xia Y., et al. Arsenite-induced aryl hydrocarbon receptor nuclear translocation results in additive induction of phase I genes and synergistic induction of phase II genes. Mol Pharmacol 68 (2005) 336-346
13. Wakui S., Yokoo K., Takahashi H., Muto T., Suzuki Y., Kanai Y., et al. CYP1 and AhR expression in 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma of rats prenatally exposed to 3,3′,4,4′,5-pentachlorobiphenyl. Toxicology 211 (2005) 231-241
14. Okey A.B., and Vella L.M. Elevated binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3-methylcholanthrene to the Ah receptor in hepatic cytosols from phenobarbital-treated rats and mice. Biochem Pharmacol 33 (1984) 531-538
15. Maglich J.M., Stoltz C.M., Goodwin B., Hawkins-Brown D., Moore J.T., and Kliewer S.A. Nuclear pregnane × receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 62 (2002) 638-646
16. Denomme M.A., Leece B., Li A., Towner R., and Safe S. Elevation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) rat hepatic receptor levels by polychlorinated biphenyls. Structure-activity relationships. Biochem Pharmacol 35 (1986) 277-282
17. Okey A.B., Bondy G.P., Mason M.E., Nebert D.W., Forster-Gibson C.J., Muncan J., et al. Temperature-dependent cytosol-to-nucleus translocation of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in continuous cell culture lines. J Biol Chem 255 (1980) 11415-11422
18. Mason M.E., and Okey A.B. Cytosolic and nuclear binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to the Ah receptor in extra-hepatic tissues of rats and mice. Eur J Biochem 123 (1982) 209-215
19. Manchester D.K., Gordon S.K., Golas C.L., Roberts E.A., and Okey A.B. Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo[a]pyrene. Cancer Res 47 (1987) 4861-4868
20. Dolwick K.M., Schmidt J.V., Carver L.A., Swanson H.I., and Bradfield C.A. Cloning and expression of a human Ah receptor cDNA. Mol Pharmacol 44 (1993) 911-917
21. Zaher H., Fernandez-Salguero P.M., Letterio J., Sheikh M.S., Fornace Jr. A.J., Roberts A.B., et al. The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis. Mol Pharmacol 54 (1998) 313-321
22. Santiago-Josefat B., Mulero-Navarro S., Dallas S.L., and Fernandez-Salguero P.M. Overexpression of latent transforming growth factor-beta binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts. J Cell Sci 117 (2004) 849-859
23. Wolff S., Harper P.A., Wong J.M., Mostert V., Wang Y., and Abel J. Cell-specific regulation of human aryl hydrocarbon receptor expression by transforming growth factor-beta(1). Mol Pharmacol 59 (2001) 716-724
24. Thomae T.L., Stevens E.A., and Bradfield C.A. Transforming growth factor-beta 3 restores fusion in palatal shelves exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem 280 (2005) 12742-12746
25. Schmidt J.V., Carver L.A., and Bradfield C.A. Molecular characterization of the murine Ahr gene. Organization, promoter analysis, and chromosomal assignment. J Biol Chem 268 (1993) 22203-22209
26. Mimura J., Ema M., Sogawa K., Ikawa S., and Fujii-Kuriyama Y. A complete structure of the mouse Ah receptor gene. Pharmacogenetics 4 (1994) 349-354
27. Eguchi H., Hayashi S., Watanabe J., Gotoh O., and Kawajiri K. Molecular cloning of the human AH receptor gene promoter. Biochem Biophys Res Commun 203 (1994) 615-622
28. FitzGerald P.C., Shlyakhtenko A., Mir A.A., and Vinson C. Clustering of DNA sequences in human promoters. Genome Res 14 (2004) 1562-1574
29. Garrison P.M., and Denison M.S. Analysis of the murine AhR gene promoter. J Biochem Mol Toxicol 14 (2000) 1-10
30. Korkalainen M., Linden J., Tuomisto J., and Pohjanvirta R. Effect of TCDD on mRNA expression of genes encoding bHLH/PAS proteins in rat hypothalamus. Toxicology 208 (2005) 1-11
31. Shimba S., Hayashi M., Ohno T., and Tezuka M. Transcriptional regulation of the AhR gene during adipose differentiation. Biol Pharm Bull 26 (2003) 1266-1271
32. Tanaka G., Kanaji S., Hirano A., Arima K., Shinagawa A., Goda C., et al. Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells. Int Immunol 17 (2005) 797-805
33. Safe S., and Wormke M. Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chem Res Toxicol 16 (2003) 807-816
34. Burke M.D., Orrenius S., and Gustafsson J.A. Pituitary involvement in the sexual differentiation and 3-methylcholanthrene induction of rat liver microsomal monooxygenases. Biochem Pharmacol 27 (1978) 1125-1128
35. Carlstedt-Duke J.M., Elfstrom G., Hogberg B., and Gustafsson J.A. Ontogeny of the rat hepatic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin and its endocrine independence. Cancer Res 39 (1979) 4653-4656
36. Timsit Y.E., Chia F.S.C., Bhathena A., and Riddick D.S. Aromatic hydrocarbon receptor expression and function in liver of hypophysectomized male rats. Toxicol Appl Pharmacol 185 (2002) 136-145
37. Monostory K., Kohalmy K., Prough R.A., Kobori L., and Vereczkey L. The effect of synthetic glucocorticoid, dexamethasone on CYP1A1 inducibility in adult rat and human hepatocytes. FEBS Lett 579 (2005) 229-235
38. Konstandi M., Johnson E., Lang M.A., Camus-Radon A.M., and Marselos M. Stress modulates the enzymatic inducibility by benzo[alpha]pyrene in the rat liver. Pharmacol Res 42 (2000) 205-211
39. Wiebel F.J., and Cikryt P. Dexamethasone-mediated potentiation of P450IA1 induction in H4IIEC3/T hepatoma cells is dependent on a time-consuming process and associated with induction of the Ah receptor. Chem Biol Interact 76 (1990) 307-320
40. Abbott B.D., Perdew G.H., Buckalew A.R., and Birnbaum L.S. Interactive regulation of Ah and glucocorticoid receptors in the synergistic induction of cleft palate by 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol Appl Pharmacol 128 (1994) 138-150
41. Brake P.B., Zhang L., and Jefcoate C.R. Aryl hydrocarbon receptor regulation of cytochrome P4501B1 in rat mammary fibroblasts: evidence for transcriptional repression by glucocorticoids. Mol Pharmacol 54 (1998) 825-833
42. Rozman K., Rozman T., Scheufler E., Pazdernik T., and Greim H. Thyroid hormones modulate the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J Toxicol Environ Health 16 (1985) 481-491
43. Henry E.C., and Gasiewicz T.A. Effects of thyroidectomy on the Ah receptor and enzyme inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat liver. Chem Biol Interact 59 (1986) 29-42
44. Rozman K., Hazelton G.A., Klaassen C.D., Arlotto M.P., and Parkinson A. Effect of thyroid hormones on liver microsomal enzyme induction in rats exposed to 2,3,7,8,-tetrachlorodibenzo-p-dioxin. Toxicology 37 (1985) 51-63
45. Lucier G.W., Tritscher A., Goldsworthy T., Foley J., Clark G., Goldstein J., et al. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res 51 (1991) 1391-1397
46. Kharat I., and Saatcioglu F. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor. Cross-talk between aryl hydrocarbon- and estrogen-mediated signalling. J Biol Chem 271 (1996) 10533-10537
47. Hoivik D., Willett K., Wilson C., and Safe S. Estrogen does not inhibit 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated effects in MCF-7 and Hepa 1c1c7 cells. J Biol Chem 272 (1997) 30270-30274
48. Jana N.R., Sarkar S., Ishizuka M., Yonemoto J., Tohyama C., and Sone H. Role of estradiol receptor-alpha in differential expression of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible genes in the RL95-2 and KLE human endometrial cancer cell lines. Arch Biochem Biophys 368 (1999) 31-39
49. Son D.S., Roby K.F., Rozman K.K., and Terranova P.F. Estradiol enhances and estriol inhibits the expression of CYP1A1 induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in a mouse ovarian cancer cell line. Toxicology 176 (2002) 229-243
50. Ohtake F., Takeyama K., Matsumoto T., Kitagawa H., Yamamoto Y., Nohara K., et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423 (2003) 545-550
51. Matthews J., Wihlen B., Thomsen J., and Gustafsson J.A. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol Cell Biol 25 (2005) 5317-5328
52. Beischlag T.V., and Perdew G.H. ER alpha-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription. J Biol Chem 280 (2005) 21607-21611
53. Spink D.C., Katz B.H., Hussain M.M., Pentecost B.T., Cao Z., and Spink B.C. Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis 24 (2003) 1941-1950
54. Wu Q., Ohsako S., Baba T., Miyamoto K., and Tohyama C. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on preimplantation mouse embryos. Toxicology 174 (2002) 119-129
55. Kahl G.F., Friederici D.E., Bigelow S.W., Okey A.B., and Nebert D.W. Ontogenetic expression of regulatory and structural gene products associated with the Ah locus. Comparison of rat, mouse, rabbit and Sigmoden hispedis. Dev Pharmacol Ther 1 (1980) 137-162
56. Gasiewicz T.A., Ness W.C., and Rucci G. Ontogeny of the cytosolic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver, lung, and thymus. Biochem Biophys Res Commun 118 (1984) 183-190
57. Sommer R.J., Sojka K.M., Pollenz R.S., Cooke P.S., and Peterson R.E. Ah receptor and ARNT protein and mRNA concentrations in rat prostate: effects of stage of development and 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment. Toxicol Appl Pharmacol 155 (1999) 177-189
58. Mikhailova O.N., Gulyaeva L.F., and Filipenko M.L. Gene expression of drug metabolizing enzymes in adult and aged mouse liver: a modulation by immobilization stress. Toxicology 210 (2005) 189-196
59. Hahn M.E. Aryl hydrocarbon receptors: diversity and evolution. Chem Biol Interact 141 (2002) 131-160
60. Powell-Coffman J.A., Bradfield C.A., and Wood W.B. Caenorhabditis elegans orthologs of the aryl hydrocarbon receptor and its heterodimerization partner the aryl hydrocarbon receptor nuclear translocator. Proc Natl Acad Sci USA 95 (1998) 2844-2849
61. Gruber C.A., Rhee J.M., Gleiberman A., and Turner E.E. POU domain factors of the Brn-3 class recognize functional DNA elements which are distinctive, symmetrical, and highly conserved in evolution. Mol Cell Biol 17 (1997) 2391-2400
62. Duncan D.M., Burgess E.A., and Duncan I. Control of distal antennal identity and tarsal development in Drosophila by spineless-aristapedia, a homolog of the mammalian dioxin receptor. Genes Dev 12 (1998) 1290-1303
63. Emmons R.B., Duncan D., Estes P.A., Kiefel P., Mosher J.T., Sonnenfeld M., et al. The spineless-aristapedia and tango bHLH-PAS proteins interact to control antennal and tarsal development in Drosophila. Development 126 (1999) 3937-3945
64. Morasso M.I., Grinberg A., Robinson G., Sargent T.D., and Mahon K.A. Placental failure in mice lacking the homeobox gene Dlx3. Proc Natl Acad Sci USA 96 (1999) 162-167
65. Lin T.M., Ko K., Moore R.W., Simanainen U., Oberley T.D., and Peterson R.E. Effects of aryl hydrocarbon receptor null mutation and in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on prostate and seminal vesicle development in C57BL/6 mice. Toxicol Sci 68 (2002) 479-487
66. Roman B.L., and Peterson R.E. In utero and lactational exposure of the male rat to 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs prostate development. 1. Effects on gene expression. Toxicol Appl Pharmacol 150 (1998) 240-253
67. Prokipcak R.D., and Okey A.B. Downregulation of the Ah receptor in mouse hepatoma cells treated in culture with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Can J Physiol Pharmacol 69 (1991) 1204-1210
68. Roberts B.J., and Whitelaw M.L. Degradation of the basic helix-loop-helix/Per-ARNT-Sim homology domain dioxin receptor via the ubiquitin/proteasome pathway. J Biol Chem 274 (1999) 36351-36356
69. Pollenz R.S. The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem Biol Interact 141 (2002) 41-61
70. Giannone J.V., Li W., Probst M., and Okey A.B. Prolonged depletion of AH receptor without alteration of receptor mRNA levels after treatment of cells in culture with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Pharmacol 55 (1998) 489-497
71. Pollenz R.S., Popat J., and Dougherty E.J. Role of the carboxy-terminal transactivation domain and active transcription in the ligand-induced and ligand-independent degradation of the mouse Ah(b-1) receptor. Biochem Pharmacol 70 (2005) 1623-1633
72. Mimura J., Ema M., Sogawa K., and Fujii-Kuriyama Y. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev 13 (1999) 20-25
73. Korkalainen M., Tuomisto J., and Pohjanvirta R. Primary structure and inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon receptor repressor in a TCDD-sensitive and a TCDD-resistant rat strain. Biochem Biophys Res Commun 315 (2004) 123-131
74. Baba T., Mimura J., Gradin K., Kuroiwa A., Watanabe T., Matsuda Y., et al. Structure and expression of the Ah receptor repressor gene. J Biol Chem 276 (2001) 33101-33110
75. Bernshausen T., Jux B., Esser C., Abel J., and Fritsche E. Tissue distribution and function of the Aryl hydrocarbon receptor repressor (AhRR) in C57BL/6 and Aryl hydrocarbon receptor deficient mice. Arch Toxicol (2005) [Epub ahead of print]
76. Yamamoto J., Ihara K., Nakayama H., Hikino S., Satoh K., Kubo N., et al. Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: organ-specific distribution and variable induction patterns in mononuclear cells. Life Sci 74 (2004) 1039-1049
77. Tsuchiya Y., Nakajima M., Itoh S., Iwanari M., and Yokoi T. Expression of aryl hydrocarbon receptor repressor in normal human tissues and inducibility by polycyclic aromatic hydrocarbons in human tumor-derived cell lines. Toxicol Sci 72 (2003) 253-259
78. Harper P.A., Wong J.Y., Lam M.S., and Okey A.B. Polymorphisms in the human AH receptor. Chem Biol Interact 141 (2002) 161-187
79. Okey A.B., Boutros P.C., and Harper P.A. Polymorphisms of human nuclear receptors that control expression of drug-metabolizing enzymes. Pharmacogenet Genomics 15 (2005) 371-379
80. Okey A.B., Franc M.A., Moffat I.D., Tijet N., Boutros P.C., Korkalainen M., et al. Toxicological implications of polymorphisms in receptors for xenobiotic chemicals: the case of the aryl hydrocarbon receptor. Toxicol Appl Pharmacol 207 (2005) S43-S51
81. Koyano S., Saito Y., Fukushima-Uesaka H., Ishida S., Ozawa S., Kamatani N., et al. Functional analysis of six human aryl hydrocarbon receptor variants in a Japanese population. Drug Metab Dispos 33 (2005) 1254-1260
82. Walisser J.A., Bunger M.K., Glover E., Harstad E.B., and Bradfield C.A. Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele. J Biol Chem 279 (2004) 16326-16331
83. Andersen M.E., and Barton H.A. Biological regulation of receptor-hormone complex concentrations in relation to dose-response assessments for endocrine-active compounds. Toxicol Sci 48 (1999) 38-50
84. Ma Q., Renzelli A.J., Baldwin K.T., and Antonini J.M. Superinduction of CYP1A1 gene expression. Regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced degradation of Ah receptor by cycloheximide. J Biol Chem 275 (2000) 12676-12683
85. Abdelrahim M., Smith III R., and Safe S. Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Mol Pharmacol 63 (2003) 1373-1381
86. Okey A.B. Enzyme induction in the cytochrome P-450 system. Pharmacol Ther 45 (1990) 241-298
87. Nebert D.W., Dalton T.P., Okey A.B., and Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279 (2004) 23847-23850
88. Ma Q., and Whitlock Jr. J.P. The aromatic hydrocarbon receptor modulates the Hepa-1c1c7 cell cycle and differentiated state independently of dioxin. Mol Cell Biol 16 (1996) 2144-2150
89. Bock K.W., and Kohle C. Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis. Biochem Pharmacol 69 (2005) 1403-1408
90. Safe S., and McDougal A. Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers. Int J Oncol 20 (2002) 1123-1128
91. Bradshaw T.D., and Westwell A.D. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate. Curr Med Chem 11 (2004) 1009-1021
92. Loaiza-Perez A.I., Kenney S., Boswell J., Hollingshead M., Alley M.C., Hose C., et al. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells. Mol Cancer Ther 3 (2004) 715-725
93. Ray S.S., and Swanson H.I. Dioxin-induced immortalization of normal human keratinocytes and silencing of p53 and p16INK4a. J Biol Chem 279 (2004) 27187-27193
94. Chesire D.R., Dunn T.A., Ewing C.M., Luo J., and Isaacs W.B. Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cells. Cancer Res 64 (2004) 2523-2533
95. Koliopanos A., Kleeff J., Xiao Y., Safe S., Zimmermann A., Buchler M.W., et al. Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer. Oncogene 21 (2002) 6059-6070
96. Gunton J.E., Kulkarni R.N., Yim S., Okada T., Hawthorne W.J., Tseng Y.H., et al. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122 (2005) 337-349
97. Bornholdt S. Systems biology. Less is more in modeling large genetic networks. Science 310 (2005) 449-451
98. Tijet N., Boutros P.C., Moffat I.D., Okey A.B., Tuomisto J., and Pohjanvirta R. The aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol 69 (2006) 140-153
99. Cartharius K., Frech K., Grote K., Klocke B., Haltmeier M., Klingenhoff A., et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21 (2005) 2933-2942